stockportfolio.pro
Stocks / NTRA vs RVMD
NTRA vs RVMD
Natera, Inc. and Revolution Medicines, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Natera, Inc. (NTRA) | Revolution Medicines, Inc. (RVMD) | |
|---|---|---|
| Market cap | $31.0B | $31.3B |
| Revenue (latest FY) | $2.31B | $0 |
| Net income (latest FY) | $-208.16M | $-1.13B |
| Revenue growth (5y CAGR) | 42.6% | — |
| Net margin | -9.0% | — |
| Return on equity | -12.2% | -69.3% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open NTRA — free Open RVMD — freeFrequently asked questions
Which is bigger, NTRA or RVMD?
Revolution Medicines, Inc. is larger by market capitalization — $31.3B versus $31.0B.
Which grows faster, NTRA or RVMD?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.